M T Sheridan1, R A Cooper, C M West. 1. CRC Section of Genome Damage and Repair, Paterson Institute for Cancer Research, Christie Hospital, Manchester, United Kingdom.
Abstract
PURPOSE: A retrospective study was made of the role of apoptosis in determining radiotherapy outcome in 39 adenocarcinoma of the cervix. A comparison was also made of the detection of apoptosis by morphology and the TdT dUtp nick end-labeling (TUNEL) assay. METHODS AND MATERIALS: The level of apoptosis was assessed in paraffin-embedded sections by cell morphology, the TUNEL assay, and a combination of the two. A total of 2,000 cells were counted per section, to obtain apoptotic (AI) and mitotic (MI) indices. RESULTS: Patients with a high AI had a higher survival rate than those with a low AI, however, the difference was not significant. Using a ratio of apoptosis to proliferation indices, patients with an AI:MI > median had significantly better survival than those with AI:MI < median. This was true where the AI was quantified by morphology alone (p = 0.030) or in combination with the TUNEL assay (p = 0.008). Where the AI was quantified by a combination of morphology and TUNEL, the 5-year survival rates for women with AI:MI greater or less than the median were 81% and 25%, respectively. CONCLUSION: A high ratio of AI:MI in adenocarcinoma of the cervix indicates a good prognosis. A combination of the TUNEL assay and morphology provided the best discrimination between outcome groups.
PURPOSE: A retrospective study was made of the role of apoptosis in determining radiotherapy outcome in 39 adenocarcinoma of the cervix. A comparison was also made of the detection of apoptosis by morphology and the TdTdUtp nick end-labeling (TUNEL) assay. METHODS AND MATERIALS: The level of apoptosis was assessed in paraffin-embedded sections by cell morphology, the TUNEL assay, and a combination of the two. A total of 2,000 cells were counted per section, to obtain apoptotic (AI) and mitotic (MI) indices. RESULTS:Patients with a high AI had a higher survival rate than those with a low AI, however, the difference was not significant. Using a ratio of apoptosis to proliferation indices, patients with an AI:MI > median had significantly better survival than those with AI:MI < median. This was true where the AI was quantified by morphology alone (p = 0.030) or in combination with the TUNEL assay (p = 0.008). Where the AI was quantified by a combination of morphology and TUNEL, the 5-year survival rates for women with AI:MI greater or less than the median were 81% and 25%, respectively. CONCLUSION: A high ratio of AI:MI in adenocarcinoma of the cervix indicates a good prognosis. A combination of the TUNEL assay and morphology provided the best discrimination between outcome groups.
Authors: Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers Journal: Eur J Nucl Med Mol Imaging Date: 2004-05-12 Impact factor: 9.236
Authors: Swaroop S Singh; Diana C Mehedint; O Harris Ford; D Antony Jeyaraj; Elena A Pop; Susan J Maygarden; Anastasia Ivanova; Rameela Chandrasekhar; Gregory E Wilding; James L Mohler Journal: Prostate Date: 2009-11-01 Impact factor: 4.104
Authors: J M Del Campo; R Hitt; P Sebastian; C Carracedo; D Lokanatha; J Bourhis; S Temam; D Cupissol; D De Raucourt; N Maroudias; C M Nutting; N Compton; D Midwinter; L Downie; N Biswas-Baldwin; I El-Hariry; K J Harrington Journal: Br J Cancer Date: 2011-08-09 Impact factor: 7.640
Authors: M M L Green; G J Hutchison; H R Valentine; R J Fitzmaurice; S E Davidson; R D Hunter; C Dive; C M L West; I J Stratford Journal: Br J Cancer Date: 2005-02-14 Impact factor: 7.640
Authors: M T Sheridan; C M West; R A Cooper; I J Stratford; J P Logue; S E Davidson; R D Hunter Journal: Br J Cancer Date: 2000-03 Impact factor: 7.640